223
Views
25
CrossRef citations to date
0
Altmetric
Research Article

Clinical impact of contrast-enhanced computed tomography combined with low-dose 18F-fluorodeoxyglucose positron emission tomography/computed tomography on routine lymphoma patient management

, , , , , , , , , , & show all
Pages 2887-2892 | Received 25 Oct 2013, Accepted 24 Feb 2014, Published online: 03 Apr 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

William L. Simpson$suffix/text()$suffix/text(), Karen M. Lee, Ninoska Sosa, Nancy Cooper, Eileen Scigliano, Joshua D. Brody, John T. Doucette & Lale Kostakoglu. (2016) Lymph nodes can accurately be measured on PET-CT for lymphoma staging/restaging without a concomitant contrast enhanced CT scan. Leukemia & Lymphoma 57:5, pages 1083-1093.
Read now

Articles from other publishers (24)

Luca Ceriani & Emanuele Zucca. 2022. Nuclear Medicine and Molecular Imaging. Nuclear Medicine and Molecular Imaging 370 386 .
Nicola M. Hughes, Heather A. Jacene, Sree Harsha Tirumani & Richard L. Wahl. 2020. Nuclear Oncology. Nuclear Oncology 1 45 .
Nicola M. Hughes, Heather A. Jacene, Sree Harsha Tirumani & Richard L. Wahl. 2022. Nuclear Oncology. Nuclear Oncology 431 474 .
Lara Marchetti, Luca Perrucci, Fabio Pellegrino, Luca Baroni, Annalisa Merlo, Massimo Tilli, Ilaria Rambaldi, Elisa Maietti, Aldo Carnevale, Mirco Bartolomei & Melchiore Giganti. (2021) Diagnostic Contribution of Contrast-Enhanced CT as Compared with Unenhanced Low-Dose CT in PET/CT Staging and Treatment Response Assessment of 18 F-FDG–Avid Lymphomas: A Prospective Study . Journal of Nuclear Medicine 62:10, pages 1372-1379.
Crossref
Mathilde Vermersch, Sébastien Mulé, Julia Chalaye, Athena Galletto Pregliasco, Berivan Emsen, Giuliana Amaddeo, Aurélien Monnet, Alto Stemmer, Laurence Baranes, Alexis Laurent, Vincent Leroy, Emmanuel Itti & Alain Luciani. (2021) Impact of the 18F-FDG-PET/MRI on Metastatic Staging in Patients with Hepatocellular Carcinoma: Initial Results from 104 Patients. Journal of Clinical Medicine 10:17, pages 4017.
Crossref
Sally F Barrington & Judith Trotman. (2021) The role of PET in the first-line treatment of the most common subtypes of non-Hodgkin lymphoma. The Lancet Haematology 8:1, pages e80-e93.
Crossref
Conrad-Amadeus Voltin, Jasmin Mettler, Ronald Boellaard, Georg Kuhnert, Markus Dietlein, Peter Borchmann, Alexander Drzezga & Carsten Kobe. (2019) Quantitative assessment of 18F-FDG PET in patients with Hodgkin lymphoma. Nuclear Medicine Communications 40:3, pages 249-257.
Crossref
Martina Panebianco, Oreste Bagni, Natalia Cenfra, Sergio Mecarocci, Elettra Ortu La Barbera, Luca Filippi, Giovanni Codacci-Pisanelli, Tommaso Biondi, Andrea Laghi & Giuseppe Cimino. (2019) Comparison of 18F FDG PET-CT AND CECT in pretreatment staging of adults with Hodgkin’s lymphoma. Leukemia Research 76, pages 48-52.
Crossref
Kenneth S. K. Yap, Ojas H. Mehta, Wing Fai Eddie Lau, Tim Akhurst, Satish Warrier, Alexander Heriot & Rodney J. Hicks. (2018) Does addition of a diagnostic contrast-enhanced CT to a contemporaneous PET/CT provide incremental value in patients for restaging of colorectal carcinoma?. European Journal of Hybrid Imaging 2:1.
Crossref
Christopher Melani, Wyndham H. Wilson & Mark Roschewski. (2018) Monitoring clinical outcomes in aggressive B-cell lymphoma: From imaging studies to circulating tumor DNA. Best Practice & Research Clinical Haematology 31:3, pages 285-292.
Crossref
Zhihua Qi, Erica L. Gates, Maureen M. O’Brien & Andrew T. Trout. (2017) Radiation dose reduction through combining positron emission tomography/computed tomography (PET/CT) and diagnostic CT in children and young adults with lymphoma. Pediatric Radiology 48:2, pages 196-203.
Crossref
Tarec Christoffer El-Galaly, Lars Christian Gormsen & Martin Hutchings. (2018) PET/CT for Staging; Past, Present, and Future. Seminars in Nuclear Medicine 48:1, pages 4-16.
Crossref
Sally F. Barrington & Kent Friedman. 2018. PET/MRI in Oncology. PET/MRI in Oncology 373 400 .
P. Tamayo, A. Martín, L. Díaz, M. Cabrero, R. García, P. García-Talavera & D. Caballero. (2017) 18 F-FDG PET/CT in the clinical management of patients with lymphoma. Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) 36:5, pages 312-321.
Crossref
P. Tamayo, A. Martín, L. Díaz, M. Cabrero, R. García, P. García-Talavera & D. Caballero. (2017) 18 F-FDG PET/TC en el manejo clínico de los linfomas. Revista Española de Medicina Nuclear e Imagen Molecular 36:5, pages 312-321.
Crossref
Heather A. Jacene, Sree Harsha Tirumani & Richard L. Wahl. 2017. Nuclear Oncology. Nuclear Oncology 353 393 .
Andrea Gallamini, Martin Hutchings & Safaa Ramadan. (2016) Clinical presentation and staging of Hodgkin lymphoma. Seminars in Hematology 53:3, pages 148-154.
Crossref
Sally F. BarringtonAmy A. KirkwoodAntonella FranceschettoMichael J. FulhamThomas H. RobertsHelén Almquist, Eva BrunKarin HjorthaugZaid N. VineyLucy C. PikeMassimo FedericoStefano LuminariJohn RadfordJudith TrotmanAlexander FossåLeanne BerkahnDaniel MolinFrancesco D’Amore, Donald A. SinclairPaul SmithMichael J. O’DohertyLindsey StevensPeter W. Johnson. (2016) PET-CT for staging and early response: results from the Response-Adapted Therapy in Advanced Hodgkin Lymphoma study. Blood 127:12, pages 1531-1538.
Crossref
Martin Hutchings, Annika Loft & Tarec Christoffer El-Galaly. 2016. PET Scan in Hodgkin Lymphoma. PET Scan in Hodgkin Lymphoma 1 13 .
Heather A. Jacene, Sree Harsha Tirumani & Richard L. Wahl. 2016. Nuclear Oncology. Nuclear Oncology 1 42 .
Michel MeignanMartin HutchingsLawrence H. Schwartz. (2015) Imaging in Lymphoma: The Key Role of Fluorodeoxyglucose‐Positron Emission Tomography. The Oncologist 20:8, pages 890-895.
Crossref
Nina F. Schwenzer & Anna Christina Pfannenberg. (2015) PET/CT, MR, and PET/MR in Lymphoma and Melanoma. Seminars in Nuclear Medicine 45:4, pages 322-331.
Crossref
Sree Harsha Tirumani, Ann S. LaCasce & Heather A. Jacene. (2015) Role of 2-Deoxy-2-[18F]-fluoro-d-glucose-PET/Computed Tomography in Lymphoma. PET Clinics 10:2, pages 207-225.
Crossref
Andrea Gallamini, Colette Zwarthoed & Anna Borra. (2014) Positron Emission Tomography (PET) in Oncology. Cancers 6:4, pages 1821-1889.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.